HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.

By X. Castellsagué, L. Alemany, M. Quer, G. Halec, B. Quirós, S. Tous, O. Clavero, L. Alós, T. Biegner, T. Szafarowski and 52 more. Journal of the National Cancer Institute, 2016

675 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics, Otorhinolaryngology

View Paper: https://www.semanticscholar.org/paper/35b0f6856a10a053c708ccba4f2b1bdc0e6b041c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Zhao Huang
2. Yunhan Tan
3. Zhihan Wang
4. Bowen Li
5. Edouard C. Nice
6. Jing Tang
7. Mengtong Xu
8. Siyuan Qin

Citations in the corpus

• Oral squamous cell carcinomas: state of the field and emerging directions (2023, background): “Consistently, p53 mutation is commonly observed in HPV OSCC, as the HPV E6 oncoprotein degrades p53.(156) In both subtypes, mutations in p53 are correlated with a lower overall survival rate, treatment resistance, and an increased risk of relapse.”